We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Integumen Plc | LSE:SKIN | London | Ordinary Share | GB00BMGWZY29 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 28.00 | 28.00 | 29.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMDVRG
RNS Number : 7936W
Deepverge PLC
19 April 2023
19 April 2023
DeepVerge plc
("DeepVerge" or "the Company" or "the Group")
Microsaic Creditor; update
DeepVerge (AIM: DVRG), the environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins, notes the notification issued by Microsaic Systems plc ("Microsaic") on 18 April 2023.
DeepVerge confirms that amounts are currently owed by DeepVerge group companies to Microsaic totalling approximately GBP1.4 million.
DeepVerge also confirms that a settlement plan ("Settlement Plan") has been proposed to Microsaic, the terms of which are substantially agreed, and that it has made an initial payment in line with that plan. In addition, DeepVerge confirms that Microsaic has continued to supply services to DeepVerge during 2023, and all amounts arising during the current financial year continue to be paid under normal 30 day terms, in line with commercial agreements between the two parties.
DeepVerge shares a common director, Nigel Burton, with Microsaic, and finalisation of the Settlement Plan will fall to be treated as a related party transaction, and will require notification, under AIM Rule 13.
DeepVerge currently expects this agreement to be agreed in due course - and until that point it is able to, and will continue to, pay amounts in line with the Settlement Plan as proposed.
Further to commentary in the Company's 17 April 2023 notification, at present the working capital position of DeepVerge is such that the sum total of its trade receivables (net of impairments) and cash balances together exceed the sum total of its trade creditors and other payable balances (with the amounts owing to Microsaic set out above included in this).
In addition, the Company has agreed payment plans, or payment phasings, with substantially all its creditors.
The Company is exploring funding options including trade finance as a stronger balance sheet would enable the Company to accelerate delivery of some existing contracts and increase confidence in seeking new business.
The Company will issue further announcements as required in line with the AIM Rules for Companies.
ENDS
Nigel Burton, Interim DeepVerge plc CEO +44 (0) 7785 234447 SPARK Advisory Partners Limited +44 (0) 113 370 (Nominated Adviser) Neil Baldwin 8974 ----------------------- -------------------- Turner Pope Investments Andy Thacker/James +44 (0) 20 3657 (TPI) Limited (Broker) Pope 0050 ----------------------- --------------------
About DeepVerge plc (www.deepverge.com)
DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins; Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
UPDEAALNFAEDEFA
(END) Dow Jones Newswires
April 19, 2023 08:21 ET (12:21 GMT)
1 Year Integumen Chart |
1 Month Integumen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions